Global Next Generation Probiotics Market Overview:
Global Next Generation Probiotics Market is expected to grow at a significant rate during the forecast period 2026-2035, with 2025 as the base year.
Global Next Generation Probiotics Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Next Generation Probiotics involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Next Generation Probiotics Market:
The Next Generation Probiotics Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Next Generation Probiotics Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Next Generation Probiotics Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Next Generation Probiotics market has been segmented into:
Akkermansia
Clostridium species
Bifidobacterium species
Lactobacillus species
and Others (Faecalibacterium
Christensenella
etc.
By Application, Next Generation Probiotics market has been segmented into:
Weight Management
Glucose Management
Inflammatory Bowel Diseases
and Others (Obesity
Metabolic Diseases
etc.
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Next Generation Probiotics market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Next Generation Probiotics market.
Top Key Players Covered in Next Generation Probiotics market are:
Pendulum
Amsterdam Winclove Probiotics
Metabogen AB (Biogaia)
Exeliom Biosciences
TargEDys
Chr. Hansen Holding A/S
YSOPIA Bioscience
A-Mansia Biotech
Next Gen Probiotics
Evolve Biosystems and DuPont de Nemours
Inc.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Next Generation Probiotics Market by Type
4.1 Next Generation Probiotics Market Snapshot and Growth Engine
4.2 Next Generation Probiotics Market Overview
4.3 Akkermansia
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Akkermansia: Geographic Segmentation Analysis
4.4 Clostridium species
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Clostridium species: Geographic Segmentation Analysis
4.5 Bifidobacterium species
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Bifidobacterium species: Geographic Segmentation Analysis
4.6 Lactobacillus species
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Lactobacillus species: Geographic Segmentation Analysis
4.7 and Others (Faecalibacterium
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 and Others (Faecalibacterium: Geographic Segmentation Analysis
4.8 Christensenella
4.8.1 Introduction and Market Overview
4.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.8.3 Key Market Trends, Growth Factors and Opportunities
4.8.4 Christensenella: Geographic Segmentation Analysis
4.9 etc.
4.9.1 Introduction and Market Overview
4.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.9.3 Key Market Trends, Growth Factors and Opportunities
4.9.4 etc.: Geographic Segmentation Analysis
Chapter 5: Next Generation Probiotics Market by Application
5.1 Next Generation Probiotics Market Snapshot and Growth Engine
5.2 Next Generation Probiotics Market Overview
5.3 Weight Management
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Weight Management: Geographic Segmentation Analysis
5.4 Glucose Management
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Glucose Management: Geographic Segmentation Analysis
5.5 Inflammatory Bowel Diseases
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Inflammatory Bowel Diseases: Geographic Segmentation Analysis
5.6 and Others (Obesity
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 and Others (Obesity: Geographic Segmentation Analysis
5.7 Metabolic Diseases
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Metabolic Diseases: Geographic Segmentation Analysis
5.8 etc.
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 etc.: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Next Generation Probiotics Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 PENDULUM
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 AMSTERDAM WINCLOVE PROBIOTICS
6.4 METABOGEN AB (BIOGAIA)
6.5 EXELIOM BIOSCIENCES
6.6 TARGEDYS
6.7 CHR. HANSEN HOLDING A/S
6.8 YSOPIA BIOSCIENCE
6.9 A-MANSIA BIOTECH
6.10 NEXT GEN PROBIOTICS
6.11 EVOLVE BIOSYSTEMS AND DUPONT DE NEMOURS
6.12 INC.
Chapter 7: Global Next Generation Probiotics Market By Region
7.1 Overview
7.2. North America Next Generation Probiotics Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Akkermansia
7.2.4.2 Clostridium species
7.2.4.3 Bifidobacterium species
7.2.4.4 Lactobacillus species
7.2.4.5 and Others (Faecalibacterium
7.2.4.6 Christensenella
7.2.4.7 etc.
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Weight Management
7.2.5.2 Glucose Management
7.2.5.3 Inflammatory Bowel Diseases
7.2.5.4 and Others (Obesity
7.2.5.5 Metabolic Diseases
7.2.5.6 etc.
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Next Generation Probiotics Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Akkermansia
7.3.4.2 Clostridium species
7.3.4.3 Bifidobacterium species
7.3.4.4 Lactobacillus species
7.3.4.5 and Others (Faecalibacterium
7.3.4.6 Christensenella
7.3.4.7 etc.
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Weight Management
7.3.5.2 Glucose Management
7.3.5.3 Inflammatory Bowel Diseases
7.3.5.4 and Others (Obesity
7.3.5.5 Metabolic Diseases
7.3.5.6 etc.
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Next Generation Probiotics Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Akkermansia
7.4.4.2 Clostridium species
7.4.4.3 Bifidobacterium species
7.4.4.4 Lactobacillus species
7.4.4.5 and Others (Faecalibacterium
7.4.4.6 Christensenella
7.4.4.7 etc.
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Weight Management
7.4.5.2 Glucose Management
7.4.5.3 Inflammatory Bowel Diseases
7.4.5.4 and Others (Obesity
7.4.5.5 Metabolic Diseases
7.4.5.6 etc.
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Next Generation Probiotics Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Akkermansia
7.5.4.2 Clostridium species
7.5.4.3 Bifidobacterium species
7.5.4.4 Lactobacillus species
7.5.4.5 and Others (Faecalibacterium
7.5.4.6 Christensenella
7.5.4.7 etc.
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Weight Management
7.5.5.2 Glucose Management
7.5.5.3 Inflammatory Bowel Diseases
7.5.5.4 and Others (Obesity
7.5.5.5 Metabolic Diseases
7.5.5.6 etc.
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Next Generation Probiotics Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Akkermansia
7.6.4.2 Clostridium species
7.6.4.3 Bifidobacterium species
7.6.4.4 Lactobacillus species
7.6.4.5 and Others (Faecalibacterium
7.6.4.6 Christensenella
7.6.4.7 etc.
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Weight Management
7.6.5.2 Glucose Management
7.6.5.3 Inflammatory Bowel Diseases
7.6.5.4 and Others (Obesity
7.6.5.5 Metabolic Diseases
7.6.5.6 etc.
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Next Generation Probiotics Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Akkermansia
7.7.4.2 Clostridium species
7.7.4.3 Bifidobacterium species
7.7.4.4 Lactobacillus species
7.7.4.5 and Others (Faecalibacterium
7.7.4.6 Christensenella
7.7.4.7 etc.
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Weight Management
7.7.5.2 Glucose Management
7.7.5.3 Inflammatory Bowel Diseases
7.7.5.4 and Others (Obesity
7.7.5.5 Metabolic Diseases
7.7.5.6 etc.
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Next Generation Probiotics Scope:
|
Report Data
|
Next Generation Probiotics Market
|
|
Next Generation Probiotics Market Size in 2025
|
USD XX million
|
|
Next Generation Probiotics CAGR 2025 - 2032
|
XX%
|
|
Next Generation Probiotics Base Year
|
2024
|
|
Next Generation Probiotics Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Pendulum, Amsterdam Winclove Probiotics, Metabogen AB (Biogaia), Exeliom Biosciences, TargEDys, Chr. Hansen Holding A/S, YSOPIA Bioscience, A-Mansia Biotech, Next Gen Probiotics, Evolve Biosystems and DuPont de Nemours, Inc..
|
|
Key Segments
|
By Type
Akkermansia
Clostridium species
Bifidobacterium species
Lactobacillus species
and Others (Faecalibacterium
Christensenella
etc.
By Applications
Weight Management
Glucose Management
Inflammatory Bowel Diseases
and Others (Obesity
Metabolic Diseases
etc.
|
